Thyroid C-mobile Tumors: In rodent experiments, semaglutide has become revealed to trigger thyroid C-cell tumors. It can be unknown no matter whether this risk applies to people, but semaglutide is contraindicated in sufferers with a personal or relatives record of medullary thyroid carcinoma (MTC) or individuals with Multiple Endocrine Neoplasia s